Generic Litigation Costs Estimated To Be $150-$300 Mil. This Year
Generic drug-related litigation costs will be between $150 mil. and $300 mil. during 2000, attorney Robert Green (Leydig, Voit and Mayer, Chicago) told the UBS Warburg specialty pharmaceuticals conference in New York City May 24.
You may also be interested in...
The Alliance for Aging Research's support of patent restoration for clinical development time echoes BIO's position on Waxman/Hatch Act reform.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials